VERA
Vera Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$35.89
+2.57%0
Insider buys (3m)
14
Insider sells (3m)
-$6.0M
Net value (3m)
+10.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 12, 2026 | Fordyce Marshall · director, officer: PRESIDENT AND CEO | Sale | 1,000 | $41 |
| Aug 12, 2026 | Fordyce Marshall · director, officer: PRESIDENT AND CEO | Sale | 88 | $38 |
| Aug 12, 2026 | Fordyce Marshall · director, officer: PRESIDENT AND CEO | Sale | 14,219 | $37 |
| Aug 12, 2026 | Fordyce Marshall · director, officer: PRESIDENT AND CEO | M-Exempt | 18,500 | $2.90 |
| Aug 12, 2026 | Fordyce Marshall · director, officer: PRESIDENT AND CEO | Sale | 32,550 | $42 |
| Aug 12, 2026 | Fordyce Marshall · director, officer: PRESIDENT AND CEO | Sale | 4,281 | $37 |
| Aug 12, 2026 | Fordyce Marshall · director, officer: PRESIDENT AND CEO | M-Exempt | 46,250 | $2.90 |
| Aug 12, 2026 | Fordyce Marshall · director, officer: PRESIDENT AND CEO | Sale | 10,500 | $43 |
| Aug 12, 2026 | Fordyce Marshall · director, officer: PRESIDENT AND CEO | Sale | 18,412 | $38 |
| Aug 12, 2026 | Fordyce Marshall · director, officer: PRESIDENT AND CEO | Sale | 2,200 | $44 |
| Aug 5, 2026 | Boman Nancy Lee · officer: Chief Regulatory Officer | A-Award | 44,987 | $0.00 |
| Aug 5, 2026 | Boman Nancy Lee · officer: Chief Regulatory Officer | A-Award | 63,011 | $32 |
| Jul 9, 2026 | Fordyce Marshall · director, officer: PRESIDENT AND CEO | Sale | 2,200 | $44 |
| Jul 9, 2026 | Fordyce Marshall · director, officer: PRESIDENT AND CEO | Sale | 10,500 | $43 |
| Jul 9, 2026 | Fordyce Marshall · director, officer: PRESIDENT AND CEO | Sale | 1,000 | $41 |
| Jul 9, 2026 | Fordyce Marshall · director, officer: PRESIDENT AND CEO | Sale | 32,550 | $42 |
| Jun 24, 2026 | Fordyce Marshall · director, officer: PRESIDENT AND CEO | Sale | 88 | $38 |
| Jun 24, 2026 | Fordyce Marshall · director, officer: PRESIDENT AND CEO | Sale | 18,412 | $38 |
| May 26, 2026 | SEIDENBERG BETH C · director | A-Award | 17,084 | $34 |
| May 26, 2026 | Cheng Andrew · director | A-Award | 17,084 | $34 |
| May 26, 2026 | Hall Kimball · director | A-Award | 17,084 | $34 |
| May 26, 2026 | Oliger Christy J. · director | A-Award | 17,084 | $34 |
| May 26, 2026 | ENRIGHT PATRICK G · director | A-Award | 17,084 | $34 |
| May 26, 2026 | Meyers James R · director | A-Award | 17,084 | $34 |
| May 26, 2026 | MORRISSEY MICHAEL · director | A-Award | 17,084 | $34 |
| May 26, 2026 | Morrison Scott W · director | A-Award | 17,084 | $34 |
| May 13, 2026 | Fordyce Marshall · director, officer: PRESIDENT AND CEO | Sale | 4,281 | $37 |
| May 13, 2026 | Fordyce Marshall · director, officer: PRESIDENT AND CEO | Sale | 14,219 | $37 |
| Apr 15, 2026 | Fordyce Marshall · director, officer: PRESIDENT AND CEO | Sale | 14,130 | $44 |
| Apr 15, 2026 | Fordyce Marshall · director, officer: PRESIDENT AND CEO | Sale | 900 | $46 |
Institutional positioning
13F filings over the trailing two quarters
New 77Increased 194Reduced 140Sold out 37
| Filer | Action | Shares | Filed |
|---|---|---|---|
| AVORO CAPITAL ADVISORS LLC | Reduced | 5,888,888 | Mar 16, 2026 |
| AVORO CAPITAL ADVISORS LLC | Reduced | 5,888,888 | May 15, 2026 |
| BlackRock, Inc. | Increased | 5,747,760 | Aug 7, 2026 |
| Avoro Capital Advisors LLC | Reduced | 5,723,888 | Aug 14, 2026 |
| BLACKROCK, INC. | Increased | 5,088,102 | May 13, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Reduced | 4,574,030 | May 15, 2026 |
| STATE STREET CORP | Increased | 4,148,786 | Aug 7, 2026 |
| DEEP TRACK CAPITAL, LP | Increased | 4,106,067 | May 15, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Reduced | 4,012,936 | Aug 14, 2026 |
| Deep Track Capital, LP | Reduced | 4,000,000 | Aug 14, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | Increased | 3,916,400 | Aug 14, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Reduced | 3,722,100 | May 15, 2026 |
| KYNAM CAPITAL MANAGEMENT, LP | Reduced | 3,398,224 | May 15, 2026 |
| STATE STREET CORP | Increased | 3,363,638 | May 15, 2026 |
| Kynam Capital Management, LP | Reduced | 2,890,059 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 12, 2026